The pharmaceutical component of the company which was carve-out in January got listed today , This is another demerger which was value accretive Pre Demerger Mkt cap was less than INR 3000 crore now separate companies have combined market cap ~INR 5000 crore
You can read a previous analysis of the company here
As far as scorecard is concerned , we would be removing both components (companies) from score card. The Pharmaceutical component at today’s trading price My rational
Life science component though close to Mr. Jasti’s heart is pure play speculative bet and tough to put a valuation figure Pharmaceuticals component is something the management may get rid off and currently at ~INR 4500 crore mcap is richly valued